Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota
Overview
Affiliations
As the global population ages, the prevalence of neurodegenerative diseases is surging. These disorders have a multifaceted pathogenesis, entwined with genetic and environmental factors. Emerging research underscores the profound influence of diet on the development and progression of health conditions. Intermittent fasting (IF), a dietary pattern that is increasingly embraced and recommended, has demonstrated potential in improving neurophysiological functions and mitigating pathological injuries with few adverse effects. Although the precise mechanisms of IF's beneficial impact are not yet completely understood, gut microbiota and their metabolites are believed to be pivotal in mediating these effects. This review endeavors to thoroughly examine current studies on the shifts in gut microbiota and metabolite profiles prompted by IF, and their possible consequences for neural health. It also highlights the significance of dietary strategies as a clinical consideration for those with neurological conditions.
Fang L, Yi X, Shen J, Deng N, Peng X Front Cell Infect Microbiol. 2025; 15:1539277.
PMID: 39963403 PMC: 11830728. DOI: 10.3389/fcimb.2025.1539277.
Sun F, Tian Y Neurochem Res. 2025; 50(1):81.
PMID: 39831923 DOI: 10.1007/s11064-025-04335-9.
Intermittent fasting as a treatment for obesity in young people: a scoping review.
Bakhsh J, Salvy S, Vidmar A NPJ Metab Health Dis. 2025; 2(1):39.
PMID: 39744147 PMC: 11685102. DOI: 10.1038/s44324-024-00041-2.
Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?.
Zhang S, Lu J, Jin Z, Xu H, Zhang D, Chen J Front Pharmacol. 2024; 15:1459655.
PMID: 39355779 PMC: 11442227. DOI: 10.3389/fphar.2024.1459655.
Intermittent Fasting in Youth: A Scoping Review.
Bakhsh J, Vidmar A, Salvy S Res Sq. 2024; .
PMID: 39011109 PMC: 11247931. DOI: 10.21203/rs.3.rs-4524102/v1.